The specificity recognized on normal allogeneic cells by a given alloreactive (1-anti-A) natural killer clone is controlled by a gene locus termed EC]. Because the EC] locus was previously shown to be located on chromosome 6, families characterized by a recombinant major histocompatibility complex haplotype were analyzed to map this locus more precisely. The breakpoint ofrecombination was studied by standard HLA typing, complement typing, and restriction fragment length polymorphism analysis of a series of genes located between the complement cluster genes and HLA-B within the major histocompatibility complex region. Three of 10 families analyzed were informative. From the data obtained, the EC] locus maps between BF and HLA-B and presumably is one of the normal genes recently described in this region.
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Although natural killer (NK) cells are generally known as cells expressing a non-major histocompatibility complex (MHC)-restricted cytotoxicity against tumor target cells (1), recent data have demonstrated that these cells may also mediate specific recognition (2) . Thus, both mixed lymphocyte culture-derived CD3-CD16+ polyclonal populations and clones were found to specifically lyse normal allogeneic cells [phytohematoglutinin (PHA)-induced blasts] derived from the stimulating donor (2) . This specific cytolytic function is clearly distinguishable from the conventional non-MHC-restricted lysis of tumor cells (3) . The charactersusceptibility to lysis-by a given alloreactive NK clone (1-anti-A) was previously shown to be inherited in an autosomic recessive fashion (thus differing from conventional MHC products) and to be carried by chromosome 6 (3). The locus regulating susceptibility or resistance to lysis by 1-anti-A NK clones has been termed ECI. Thus, allogeneic target cells susceptible to lysis are presumed homozygous for the recessive allele (ECI -/-), whereas the characterresistance to lysis-is conferred by a dominant allele, either in an heterozygous (ECI +/-) or in an homozygous (ECI +/+) configuration. In this paper, mapping of the ECI locus in the MHC region between HLA-B and BF in the complement gene cluster is described. This region has recently been shown to carry 15 normal genes of presently unknown function (4). Pharmaceuticals, Raritan, NJ), anti-CD4 (HP26), and anti-CD8 (B9.4) monoclonal antibodies followed by treatment with rabbit complement for 1 hr at 37°C (2, 3) . Viable cells were isolated by Ficoll/Hypaque gradients and cultured in microwells (5 x 104 cells per well) in the presence of allogeneic irradiated mononuclear cells; after 4 days, the cultures were supplemented with recombinant interleukin 2 at 100 units/ml. The mixed lymphocyte culture-derived cells were cloned under limiting-dilution conditions in -the presence of allogeneic irradiated feeder cells and recombinant interleukin 2 at 100 units/ml (2, 3, 5) . Ten to twenty days later the cytolytic activity was tested in a 4-hr 51Cr-release assay, in which effector cells were tested against PHA blasts derived from different allogeneic (or autologous) donors. PHA blasts were obtained by culturing peripheral blood lymphocytes for 4 days with 0.5% PHA (vol/vol) and recombinant interleukin 2 at 100 units/ml. In some experiments, fresh uncultured tumor cells were the target cells; target cells were used at 5 x 103 cells per well for a final effector/target cell ratio of 5:1. Percent specific lysis was determined as described (6). 1-anti-A alloreactive NK clones were selected as has been described (3).
MATERIALS AND METHODS
HLA Typing. Serological typing for HLA-A, -B, and -C antigens was done by the standard National Institutes of Health technique (7) . Serological typing for HLA-DR and HLA-DQ was performed on B-lymphocyte-enriched suspensions from peripheral blood by using the long-incubation lymphocytotoxicity technique with reagents obtained both locally and abroad (8) .
Complement Typing. For analysis of complement polymorphisms, serum was separated from fresh blood and preserved at -80°C. C4 phenotypes were determined in neuraminidaseand carboxypeptidase B-treated serum samples (9) by using the technique of immunofixation electrophoresis in 0.45% (wt/vol) agarose gels (Seakem ME, FMC). Buffer for the analysis was a discontinuous Tris/glycine/barbital system. Immunofixation of the C4 bands was achieved with sheep anti-human C4, nephelometric grade (Serotec). C4-dependent lysis was performed with sensitized sheep erythrocytes in 1% (wt/vol) agarose overlay (Seakem ME) containing C4-deficient guinea pig serum (provided by G. Hauptmann, Strasbourg, France). The presence ofthe null gene at the C4A or C4B loci was determined from the different intensity of the bands for the two loci after staining with Coomassie blue. BF phenotypes were determined by high-voltage electrophoresis of serum in 0.6% (wt/vol) agarose gels (ICN and Abbreviations: MHC, major histocompatibility complex; NK, natural killer; PHA, phytohemagglutinin.
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Litex HSA, Denmark) followed by immunofixation with goat anti-human factor B (Atlantic Antibodies, Scarborough, ME) (10) .
Restriction Fragment Length Polymorphism Analysis. Genomic DNA was prepared by standard techniques. DNA samples were digested with Taq I (New England Biolabs), according to the manufacturer's specifications. The DNA fragments were electrophoresed on 0.8% agarose gel and blotted into nylon membrane (Hybond-N, Amersham). The BAT3 probe consisted of a BamHI-Xba I fragment from the BAT3 cDNA clone (11) . The BAT3 probe was radiolabeled with [a-32P]dCTP (NEN) by the random-primer procedure. Filters were hybridized 16 hr at 65°C in 6x SSC (1x SSC is 0.15 M sodium chloride/0.015 M sodium citrate, pH 7), washed 10 min at room temperature in 5 X SSC for three times, 10 min each, at 650C in 0.1 x SSC buffer, and exposed to XAR films (Kodak) for 16-48 hr.
RESULTS
To map the ECI locus on chromosome 6, 10 families exhibiting recombinant MHC haplotypes were analyzed. PHAinduced blast cells from each family member were tested for susceptibility to lysis by a set of NK clones displaying 1-anti-A specificity. Three ofthese families were informative, and the relevant HLA marker combinations oftheir members are shown in Fig. 1 . Analysis of the HLA markers in the R family, including the complement genes, indicated that donor R3 carried a recombinant haplotype. The recombination involved the maternal gametes, and the breakpoint could be localized between the BF gene in the complement cluster and HLA-B. Blast cells from donor R1 were susceptible to lysis (Table 1) , thus suggesting that this individual was homozygous for the recessive allele of the locus ECI (-/-). Cells from the R2 donor were resistant to lysis. In this donor, locus ECI was in a heterozygote configuration (+/-), as indicated by the fact that both resistant and susceptible individuals were present in the progeny. The family segregation analysis indicates that the recessive EC] -allele segregates with the c haplotype, whereas the dominant EC] + allele segregates with the d haplotype. Because donor R3 (carrying the recombinant c/d haplotype) was susceptible to lysis, she must be homozygous for locus ECI (-/-). Thus, it appears that the EC- allele is inherited in association with markers that are telomeric to the BF gene.
Further analysis of the two other informative families allowed mapping of the ECI locus between class I and complement cluster genes. In family M, donor M5 carried a recombinant haplotype of paternal derivation. In this donor, the breakpoint was located between the A and C loci of class I genes (Fig. 1) . Analysis of susceptibility of lysis by 1-anti-A NK clones revealed that donor Ml was heterozygous for the EC] locus (+/-), whereas his mate (donor M2) was susceptible to lysis and, thus, homozygous (-/-). Donor M5 was resistant to lysis and, thus, the locus ECI must be heterozygous (+/-). In this case, the ECI + allele was carried by the recombinant haplotype. Analysis of segregation of the pater- I--. -P% I-nal haplotype clearly indicated that the EC1+ allele was carried by the b haplotype. Therefore, it is possible to conclude that the ECI locus maps centromeric to HLA-A.
In the third family (G,) the donor G3 carried a recombinant haplotype derived from the mother (G2). In this case, the breakpoint was localized between the HLA-B and HLA-DR loci by HLA typing. Donor' G2 was heterozygous for ECI (+/-), whereas donor G1 was homozygous (-/-). Because PHA blast cells of donor G3 were susceptible to lysis by 1-anti-A NK clones, we conclude that the ECI-allele is carried by the recombinant haplotype. Analysis of the segregation in the family members indicated that the recessive ECI-allele, of maternal derivation, is associated with the d haplotype. Thus, the ECI locus appears centromeric to the HLA-B locus.
To better define the breakpoint in families G and R, the restriction fragment length polymorphism using a set of probes derived from the MHC between HLA-B locus and the C2 gene was studied. Analysis with a BAT3 cDNA probe was informative in family G. The cDNA/restriction enzyme combination BAT3/Taq I identified polymorphic bands at 2.5 and 2.7 kilobases (kb), which showed allelic behavior and codominant segregation (Fig. 2) . In the G family, the 2.5-kb band cosegregated with the d haplotype (Fig. 2) . Because the recombinant G3 donor showed a d haplotype for the BAT3 gene and a' c haplotype for the class I HLA genes, the breakpoint of recombination was between the BAT3 and HLA-B loci. Thus, the breakpoint is clearly centromeric to HLA-B.
DISCUSSION
In the present paper, locus ECI governing the expression of susceptibility to lysis by 1-anti-A NK clones is shown to be contained in the MHC region between the class I and complement clusters (Fig. 3) . This region includes at least 15 genes ofunknown structure and function as well as two tumor necrosis factor and two heat shock protein genes (4, (11) (12) (13) (14) . One of these genes might be involved in the expression of the alloantigen recognized by NK cells. Further studies of DNA polymorphisms in the recombinant families may make it possible to localize ECI in a narrower genetic region.
It should be stressed that the character-susceptibility to lysis-is inherited in a recessive fashion. A possible explanation is that the ECI locus is not coding for the alloantigen itself but rather represents a regulatory gene that controls expression of the alloantigen. In this hypothesis, the activity CLASS 1I trait. Several distinct susceptibility antigens could be accounted for by different degrees of incompleteness of the glycan, as the Lewis trait in the blood group system. Other types of protein modification could also meet the criteria for this system, but a recessive susceptibility trait is not easily accounted for by an amino acid polymorphism in the protein itself.
The ability of human NK cells to recognize and lyse normal allogeneic cells may have a murine counterpart in the socalled "hybrid resistance" (Hh-1) phenomenon. This phenomenon refers to the ability of murine NK cells to reject H-2-compatible Hh-1-incompatible bone-marrow grafts. The Hh-1 alloantigens were shown to be recessively inherited and encoded in the murine MHC on chromosome 17 (15, 16) . It is evident that the data obtained in the murine system are consistent with the human data presented here. In this study, locus ECI was mapped between the complement and class I gene clusters. Interestingly, also in mice, the Hh-1 genes were mapped between H-2S (complement) and H-2D (class I) (17) .
The present data further support the concept that, as in mice, another family of NK-defined alloantigen exists in humans. Preliminary experiments also suggest that the ECI locus is polymorphic, as indicated by the existence of several NK-defined specificities (ref. 3 and E.C., unpublished work). Although the biological relevance of NK-mediated alloantigen recognition is presently unknown, this phenomenon could have important implications in human bone-marrow transplantation.
